Notizie dei mercati

Nautilus Biotechnology, Inc.: Morgan Stanley mantiene la raccomandazione Neutral

This content has been archived. It may no longer be relevant

Nautilus Biotechnology, Inc.: Morgan Stanley mantiene la raccomandazione Neutral

Nautilus Biotechnology Morgan


FIMA2614# 2022-08-03T17:01:30+02:00

Show More